MRM Stock Catalyst: MEDIROM MOTHER Labs Inc. Secures ¥9 Billion in Series A Financing

Oct 8, 2025 · 7:42pm ET

MEDIROM MOTHER Labs Inc. announced its Series A financing round.

Max move

+52.0%

High of day $3.09

Sparker timei

7:42pm ET

MRM · Oct 8, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

MEDIROM MOTHER Labs Inc., a subsidiary of MEDIROM Healthcare Technologies Inc. (XNAS: MRM), announced on October 9, 2025, that it has secured ¥9 billion in investment from internal investors as part of its Series A financing round.

The investment amount totals ¥9 billion. The financing round is intended to support the company's growth initiatives.

As of the latest available data, MEDIROM Healthcare Technologies Inc. has a free float of 5,822,000 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time MRM sparks.

Download Sniper App →

Catch the next MRM-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →